Sixth ovarian cancer consensus conference on clinical research of the gynecologic cancer InterGroup
File(s)
Accepted version
Author(s)
Type
Journal Article
Abstract
The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical Research (OCCC6) was held virtually in October 2021 following published consensus guidelines. All 33 GCIG member groups participated in the development, refinement, and adoption of 20 statements within 4 topic groups on clinical research including first line treatment, recurrent disease, disease subgroups and future trials. Unanimous consensus was obtained for 14 of 20 statements, with >90% concordance in the remaining 6 statements. The high acceptance rate following active deliberation amongst the GCIG groups confirmed that a consensus process could be applied in a virtual setting. Together with detailed categorisation of unmet needs, these consensus statements will promote harmonisation of international clinical research in ovarian cancer.
Date Issued
2022-08-01
Date Acceptance
2022-02-23
Citation
The Lancet Oncology, 2022, 23 (8), pp.e374-e384
ISSN
1213-9432
Publisher
Elsevier
Start Page
e374
End Page
e384
Journal / Book Title
The Lancet Oncology
Volume
23
Issue
8
Copyright Statement
© 2022 Elsevier Ltd. All rights reserved. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Publication Status
Published
Date Publish Online
2022-07-25